We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Horizon Broadens Industry-leading Gene Editing Capabilities

News   Jan 17, 2017 | Original story from Horizon Discovery

 
Horizon Broadens Industry-leading Gene Editing Capabilities
 
 
 

RELATED ARTICLES

Promising Results From Experimental HIV Vaccine

News

An experimental HIV vaccine has reached an important milestone by eliciting antibodies that can neutralize a wide variety of HIV strains.

READ MORE

Safety and Efficacy Results From CRISPR/Cas9 Human Clinical Trials Are Positive

News

CRISPR Therapeutics and Vertex Pharmaceuticals have announced their interim safety and efficacy results from the CTX001 CRISPR/Cas9 gene-editing human clinical trials - and they're promising.

READ MORE

A Milestone Is Reached For New Leukemia Drug

News

Cold Spring Harbor Laboratory scientists, with chemists and cancer biologists from Dana-Farber Cancer Institute (DFCI), have developed a new therapy that extended the survival of mice with acute myeloid leukemia.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE